Colorectal Cancer Canada’s Conferences

CCC has hosted this seminal pan-cancer clinical trials conference over the last 8 years, uniting clinical trial networks, researchers, industry, academics, trial sponsors, HTA agencies, Health Canada, and national and international cancer patient groups to mention a few.

Over the course of the past several years, we have made considerable progress in fostering patient and patient group partnerships among researchers and stakeholders engaged in cancer clinical trials and their engagement in the clinical trial continuum with a view to increasing access to trials with endpoints that are meaningful to patients.

This year, join us for our 9th Annual Patient-Centered Approach to Clinical Trials Conference where we will explore ‘RESEARCH IS CARE AND CARE IS RESEARCH: Unlocking faster innovation for better access, outcomes and hope’.

Clinical trials are a vital step in the development of new treatments for colorectal cancer patients, and an opportunity for patients to have access to certain treatments earlier than otherwise possible. However, the number of cancer patients enrolled in clinical trials in Canada has for the past few years hovered between two and six percent, despite regular andrecurring interest from patients. Low participation can sink trials, delaying the approval of potentially life-saving drugs. Recognizing this important gap in Canada, CCC has hosted seven annual clinical trials conferences to bring relevant stakeholders together. The goal is to develop a Canadian clinical trials transformation initiative that includes the patient voice in the process.

Access the recordings from past conferences below.